These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study. Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338 [TBL] [Abstract][Full Text] [Related]
5. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658 [TBL] [Abstract][Full Text] [Related]
6. On the importance of accurate quantification of individual volatile metabolites in exhaled breath. Smith D; Španěl P J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619 [TBL] [Abstract][Full Text] [Related]
7. A study of 9 common breath VOCs in 504 healthy subjects using PTR-TOF-MS. Jia Z; Ong WQ; Zhang F; Du F; Thavasi V; Thirumalai V Metabolomics; 2024 Jul; 20(4):79. PubMed ID: 39046579 [TBL] [Abstract][Full Text] [Related]
8. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection? Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768 [TBL] [Abstract][Full Text] [Related]
9. A rapid method for breath analysis in cystic fibrosis patients. Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis. Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686 [TBL] [Abstract][Full Text] [Related]
11. Analysis of volatile organic compounds from deep airway in the lung through intubation sampling. Xu W; Zhang J; Ding H; Ding Y; Zou X; Yang M; Zhou Q; Liu Z; Zheng L; Zuo H; Ge D; Zhang Q; Huang C; Shen C; Chu Y Anal Bioanal Chem; 2022 Nov; 414(26):7647-7658. PubMed ID: 36018334 [TBL] [Abstract][Full Text] [Related]
12. Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical research. Lamy E; Roquencourt C; Zhou B; Salvator H; Moine P; Annane D; Devillier P; Bardin E; Grassin-Delyle S Anal Bioanal Chem; 2024 Sep; 416(22):4929-4939. PubMed ID: 38980330 [TBL] [Abstract][Full Text] [Related]
13. Detection of Staphylococcus aureus in cystic fibrosis patients using breath VOC profiles. Neerincx AH; Geurts BP; van Loon J; Tiemes V; Jansen JJ; Harren FJ; Kluijtmans LA; Merkus PJ; Cristescu SM; Buydens LM; Wevers RA J Breath Res; 2016 Nov; 10(4):046014. PubMed ID: 27902490 [TBL] [Abstract][Full Text] [Related]
14. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711 [TBL] [Abstract][Full Text] [Related]
15. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis. Licht JC; Seidl E; Slingers G; Waters V; de Vries R; Post M; Ratjen F; Grasemann H J Cyst Fibros; 2023 Sep; 22(5):888-893. PubMed ID: 36849333 [TBL] [Abstract][Full Text] [Related]
16. Extending PTR based breath analysis to real-time monitoring of reactive volatile organic compounds. Pugliese G; Trefz P; Brock B; Schubert JK; Miekisch W Analyst; 2019 Dec; 144(24):7359-7367. PubMed ID: 31663533 [TBL] [Abstract][Full Text] [Related]
17. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis. van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305 [TBL] [Abstract][Full Text] [Related]
18. Online exhaled gas measurements for radiotherapy patients by proton transfer reaction mass spectrometry. Zou X; Zhou W; Shen C; Wang H; Lu Y; Wang H; Chu Y J Environ Radioact; 2016 Aug; 160():135-40. PubMed ID: 27209162 [TBL] [Abstract][Full Text] [Related]
19. Cross Platform Analysis of Volatile Organic Compounds Using Selected Ion Flow Tube and Proton-Transfer-Reaction Mass Spectrometry. Lin GP; Vadhwana B; Belluomo I; Boshier PR; Španěl P; Hanna GB J Am Soc Mass Spectrom; 2021 May; 32(5):1215-1223. PubMed ID: 33831301 [TBL] [Abstract][Full Text] [Related]
20. Effects of humidity, CO Trefz P; Schubert JK; Miekisch W J Breath Res; 2018 Mar; 12(2):026016. PubMed ID: 29199640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]